Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Best Practices for Pharmacists to Optimize Use of Obesity Treatment Options and Overcome Barriers to Care

In this podcast episode, Drs Megan Adelman and Elizabeth Pogge review obesity treatment options, with a focus on injectable therapies and overcoming barriers to care.
Megan Adelman, PharmD, BCPS, BCGP, CDCES
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA
Released: April 22, 2022

In this episode, pharmacists Megan Adelman, PharmD, BCPS, BCGP, CDCES, and Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, provide an overview of obesity, including pathophysiology and the benefits of long-term weight loss, and discuss guideline recommendations for treatment, pharmacotherapy options including injectable agents, and overcoming barriers to care.

Information on this Educational Activity

Faculty

Megan Adelman, PharmD, BCPS, BCGP, CDCES

Family Medicine Pharmacy Specialist
Center for Family Medicine
Cleveland Clinic Akron General
Akron, Ohio

Megan Adelman, PharmD, BCPS, BCGP, CDCES, has no relevant conflicts of interest to report.
Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA

Professor 
Department of Pharmacy Practice
College of Pharmacy-Glendale
Midwestern University
Glendale, Arizona

Elizabeth Pogge, PharmD, MPH, BCPS-AQ Cardiology, BCGP, FASCP, FAzPA, has no relevant conflicts of interest to report.

Program Medium

This program has been made available online.

Acknowledgements

Provided by ProCE, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Novo Nordisk Inc.

Related Content

Experts discuss practical use of CGM in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)

Martin J. Abrahamson, MD, FACP
Program Director
Leslie Eiland, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Registered Nurses: 1.0 Nursing contact hour Physician Assistants: maximum of 1.0 hour of AAPA Category 1 CME credit Released: May 27, 2022 Expired: May 26, 2023

Expert faculty summarize key evidence for finerenone use in diabetic kidney disease, selecting patients for therapy, and the role of the pharmacist, from ProCE

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Released: May 17, 2022

Expert faculty insight on evidence for finerenone use in DKD, selecting patients for therapy, overcoming clinical inertia, from ProCE

Diana Isaacs, PharmD, BCPS, BCACP, CDCES, BC-ADM, FADCES, FCCP Joshua J. Neumiller, PharmD, CDCES, FADCES, FASCP Pharmacists: 1.5 contact hours (0.15 CEUs) Released: April 29, 2022 Expired: April 28, 2023

Downloadable slides on CGM use in clinical practice, with a focus on overcoming barriers to integration, from Clinical Care Options (CCO)

Martin J. Abrahamson, MD, FACP
Program Director
Leslie Eiland, MD
Released: April 27, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings